CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
22.29
-1.09 (-4.66%)
At close: Feb 21, 2025, 4:00 PM
22.18
-0.11 (-0.49%)
After-hours: Feb 21, 2025, 6:46 PM EST
CareDx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CareDx stock have an average target of 26.43, with a low estimate of 15 and a high estimate of 35. The average target predicts an increase of 18.57% from the current stock price of 22.29.
Analyst Consensus: Buy
* Price targets were last updated on Jan 15, 2025.
Analyst Ratings
The average analyst rating for CareDx stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell → Hold Upgrades $28 → $24 | Sell → Hold | Upgrades | $28 → $24 | +7.67% | Jan 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $26 | Hold | Reiterates | $26 | +16.64% | Jan 14, 2025 |
| BTIG | BTIG | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +57.02% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 22, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $35 | Strong Buy | Maintains | $26 → $35 | +57.02% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
337.96M
from 280.32M
Increased by 20.56%
Revenue Next Year
376.90M
from 337.96M
Increased by 11.52%
EPS This Year
0.51
from -3.54
EPS Next Year
0.59
from 0.51
Increased by 16.29%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 349.7M | 391.2M | 457.9M | |
| Avg | 338.0M | 376.9M | 432.5M | |
| Low | 322.5M | 357.8M | 405.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 24.7% | 15.8% | 21.5% | |
| Avg | 20.6% | 11.5% | 14.8% | |
| Low | 15.1% | 5.9% | 7.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.59 | 0.75 | 1.23 | |
| Avg | 0.51 | 0.59 | 0.89 | |
| Low | 0.41 | 0.50 | 0.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 46.2% | 107.1% | |
| Avg | - | 16.3% | 50.8% | |
| Low | - | -2.0% | -70.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.